Edition:
United Kingdom

Imprimis Pharmaceuticals Inc (IMMY.OQ)

IMMY.OQ on NASDAQ Stock Exchange Capital Market

5.83USD
14 Dec 2018
Change (% chg)

$-0.12 (-2.02%)
Prev Close
$5.95
Open
$5.90
Day's High
$5.90
Day's Low
$5.62
Volume
89,927
Avg. Vol
78,226
52-wk High
$6.49
52-wk Low
$1.46

Latest Key Developments (Source: Significant Developments)

Imprimis Pharmaceuticals Reports Q2 EPS $0.12
Monday, 6 Aug 2018 

Aug 6 (Reuters) - Imprimis Pharmaceuticals Inc ::IMPRIMIS PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2018 RESULTS.Q2 REVENUE ROSE 51 PERCENT TO $10.4 MILLION.QTRLY NET INCOME PER COMMON SHARE $0.12.  Full Article

Imprimis Pharmaceuticals Issued Composition Patent For Non-Opioid Conscious Sedation Formulation
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Imprimis Pharmaceuticals Inc ::IMPRIMIS PHARMACEUTICALS ISSUED COMPOSITION PATENT FOR NON-OPIOID CONSCIOUS SEDATION FORMULATION.IMPRIMIS PHARMACEUTICALS INC - ‍SECURED A PATENT COVERING COMPANY'S MKO MELT COMPOUNDED FORMULATION​.  Full Article

Imprimis Pharmaceuticals Q3 loss per share $‍0.28​
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Imprimis Pharmaceuticals Inc :Imprimis Pharmaceuticals announces third quarter 2017 results.Q3 revenue rose 34 percent to $6.5 million.Imprimis Pharmaceuticals inc qtrly loss per share $‍0.28​.  Full Article